Rank | Gene Set | Z-score |
---|---|---|
1 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.66876945 |
2 | lysine metabolic process (GO:0006553) | 4.56743079 |
3 | lysine catabolic process (GO:0006554) | 4.56743079 |
4 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.27594431 |
5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.24575049 |
6 | L-phenylalanine metabolic process (GO:0006558) | 4.24575049 |
7 | regulation of ARF protein signal transduction (GO:0032012) | 4.20054016 |
8 | negative regulation of cell killing (GO:0031342) | 4.17099359 |
9 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.17099359 |
10 | L-phenylalanine catabolic process (GO:0006559) | 4.15646305 |
11 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.15646305 |
12 | 2-oxoglutarate metabolic process (GO:0006103) | 3.98012081 |
13 | alpha-linolenic acid metabolic process (GO:0036109) | 3.97411331 |
14 | synaptic vesicle exocytosis (GO:0016079) | 3.96373135 |
15 | glutamate secretion (GO:0014047) | 3.87635439 |
16 | synaptic vesicle maturation (GO:0016188) | 3.85855170 |
17 | aspartate family amino acid catabolic process (GO:0009068) | 3.81145139 |
18 | glyoxylate metabolic process (GO:0046487) | 3.76256415 |
19 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.64206192 |
20 | signal complex assembly (GO:0007172) | 3.61782768 |
21 | regulation of cholesterol homeostasis (GO:2000188) | 3.51932849 |
22 | kynurenine metabolic process (GO:0070189) | 3.51463920 |
23 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.50641632 |
24 | carnitine shuttle (GO:0006853) | 3.50123103 |
25 | cellular ketone body metabolic process (GO:0046950) | 3.49162918 |
26 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.45524612 |
27 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.42732254 |
28 | fatty acid transmembrane transport (GO:1902001) | 3.42469187 |
29 | sulfur amino acid catabolic process (GO:0000098) | 3.41869125 |
30 | positive regulation of Rap GTPase activity (GO:0032854) | 3.41548805 |
31 | aromatic amino acid family catabolic process (GO:0009074) | 3.38366678 |
32 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.37820999 |
33 | cerebellar granule cell differentiation (GO:0021707) | 3.37433100 |
34 | positive regulation of synapse maturation (GO:0090129) | 3.37271277 |
35 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.36972077 |
36 | positive thymic T cell selection (GO:0045059) | 3.36870457 |
37 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.34831169 |
38 | cysteine metabolic process (GO:0006534) | 3.33805847 |
39 | thymic T cell selection (GO:0045061) | 3.30833944 |
40 | cellular potassium ion homeostasis (GO:0030007) | 3.29757825 |
41 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.29048705 |
42 | tricarboxylic acid metabolic process (GO:0072350) | 3.28126564 |
43 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.25900120 |
44 | fatty acid beta-oxidation (GO:0006635) | 3.24319953 |
45 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.22649734 |
46 | glutamate metabolic process (GO:0006536) | 3.21589074 |
47 | short-chain fatty acid metabolic process (GO:0046459) | 3.21398294 |
48 | plasma membrane repair (GO:0001778) | 3.21302435 |
49 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.19552222 |
50 | cellular modified amino acid catabolic process (GO:0042219) | 3.18010554 |
51 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.16071391 |
52 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.14683991 |
53 | oxaloacetate metabolic process (GO:0006107) | 3.12670917 |
54 | regulation of fatty acid oxidation (GO:0046320) | 3.12295580 |
55 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.12285320 |
56 | acetyl-CoA metabolic process (GO:0006084) | 3.12129927 |
57 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.10314115 |
58 | sarcomere organization (GO:0045214) | 3.08142979 |
59 | tricarboxylic acid cycle (GO:0006099) | 3.07569837 |
60 | bile acid biosynthetic process (GO:0006699) | 3.07491151 |
61 | amino-acid betaine metabolic process (GO:0006577) | 3.04973304 |
62 | regulation of triglyceride catabolic process (GO:0010896) | 3.02475724 |
63 | ketone body metabolic process (GO:1902224) | 3.00774246 |
64 | fatty acid oxidation (GO:0019395) | 2.96347030 |
65 | negative regulation of fibrinolysis (GO:0051918) | 2.96331369 |
66 | fatty acid catabolic process (GO:0009062) | 2.93797462 |
67 | 4-hydroxyproline metabolic process (GO:0019471) | 2.93255236 |
68 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.92266932 |
69 | positive regulation of fatty acid oxidation (GO:0046321) | 2.91893207 |
70 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.91868309 |
71 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.91023613 |
72 | lipid oxidation (GO:0034440) | 2.90324554 |
73 | negative regulation of cell size (GO:0045792) | 2.90292112 |
74 | ethanol oxidation (GO:0006069) | 2.90111065 |
75 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.89374538 |
76 | valine metabolic process (GO:0006573) | 2.87581560 |
77 | response to mercury ion (GO:0046689) | 2.86676663 |
78 | urea cycle (GO:0000050) | 2.86198897 |
79 | urea metabolic process (GO:0019627) | 2.86198897 |
80 | monocarboxylic acid catabolic process (GO:0072329) | 2.85025783 |
81 | regulation of Rap GTPase activity (GO:0032317) | 2.84794113 |
82 | high-density lipoprotein particle remodeling (GO:0034375) | 2.84015889 |
83 | negative regulation of cholesterol transport (GO:0032375) | 2.80777624 |
84 | negative regulation of sterol transport (GO:0032372) | 2.80777624 |
85 | protein carboxylation (GO:0018214) | 2.80416911 |
86 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.80416911 |
87 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.80341619 |
88 | T cell selection (GO:0045058) | 2.78541363 |
89 | regulation of synaptic vesicle transport (GO:1902803) | 2.78139407 |
90 | positive T cell selection (GO:0043368) | 2.78102880 |
91 | positive regulation of protein dephosphorylation (GO:0035307) | 2.77081387 |
92 | NADH metabolic process (GO:0006734) | 2.76723552 |
93 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.76459479 |
94 | serine family amino acid catabolic process (GO:0009071) | 2.76169940 |
95 | positive regulation of lipid catabolic process (GO:0050996) | 2.76028239 |
96 | dicarboxylic acid catabolic process (GO:0043649) | 2.75905254 |
97 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.75715454 |
98 | alpha-amino acid catabolic process (GO:1901606) | 2.75700663 |
99 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.75673860 |
100 | regulation of ARF GTPase activity (GO:0032312) | 2.75375122 |
101 | cardiac myofibril assembly (GO:0055003) | 2.75067520 |
102 | tryptophan catabolic process (GO:0006569) | 2.75000809 |
103 | indole-containing compound catabolic process (GO:0042436) | 2.75000809 |
104 | indolalkylamine catabolic process (GO:0046218) | 2.75000809 |
105 | locomotory exploration behavior (GO:0035641) | 2.73876970 |
106 | neurotransmitter secretion (GO:0007269) | 2.73496756 |
107 | homocysteine metabolic process (GO:0050667) | 2.73306408 |
108 | carnitine transport (GO:0015879) | 2.73187541 |
109 | amino-acid betaine transport (GO:0015838) | 2.73187541 |
110 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.73186428 |
111 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.72718822 |
112 | cellular amino acid catabolic process (GO:0009063) | 2.72469412 |
113 | cell communication by electrical coupling (GO:0010644) | 2.72434660 |
114 | succinate metabolic process (GO:0006105) | 2.72107045 |
115 | cell communication involved in cardiac conduction (GO:0086065) | 2.71452085 |
116 | activation of protein kinase A activity (GO:0034199) | 2.70841417 |
117 | negative thymic T cell selection (GO:0045060) | 2.69874572 |
118 | mannose metabolic process (GO:0006013) | 2.69489565 |
119 | carnitine transmembrane transport (GO:1902603) | 2.68243203 |
120 | cardiac muscle contraction (GO:0060048) | 2.66849487 |
121 | sodium ion export (GO:0071436) | 2.66307436 |
122 | nitrogen cycle metabolic process (GO:0071941) | 2.65108653 |
123 | regulation of synapse maturation (GO:0090128) | 2.64719024 |
124 | creatine metabolic process (GO:0006600) | 2.64359635 |
125 | negative T cell selection (GO:0043383) | 2.64128489 |
126 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.64048549 |
127 | carnitine metabolic process (GO:0009437) | 2.62342461 |
128 | complement activation, alternative pathway (GO:0006957) | 2.61901193 |
129 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.60851914 |
130 | bile acid metabolic process (GO:0008206) | 2.60263848 |
131 | coenzyme catabolic process (GO:0009109) | 2.59320434 |
132 | drug catabolic process (GO:0042737) | 2.59102707 |
133 | triglyceride homeostasis (GO:0070328) | 2.58248260 |
134 | acylglycerol homeostasis (GO:0055090) | 2.58248260 |
135 | plasma lipoprotein particle clearance (GO:0034381) | 2.58105352 |
136 | phospholipid homeostasis (GO:0055091) | 2.57537061 |
137 | regulation of gamma-delta T cell activation (GO:0046643) | 2.56884184 |
138 | L-amino acid import (GO:0043092) | 2.56774284 |
139 | regulation of extracellular matrix disassembly (GO:0010715) | 2.56626074 |
140 | reverse cholesterol transport (GO:0043691) | 2.55221927 |
141 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.53925796 |
142 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.53642317 |
143 | organic acid catabolic process (GO:0016054) | 2.52578333 |
144 | carboxylic acid catabolic process (GO:0046395) | 2.52578333 |
145 | tryptophan metabolic process (GO:0006568) | 2.51745521 |
146 | regulation of fibrinolysis (GO:0051917) | 2.51421891 |
147 | activation of MAPKKK activity (GO:0000185) | 2.50515045 |
148 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.48622101 |
149 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.47077357 |
150 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.46688521 |
151 | leukocyte aggregation (GO:0070486) | 2.46355002 |
152 | protein targeting to plasma membrane (GO:0072661) | 2.44966051 |
153 | tolerance induction (GO:0002507) | 2.44646877 |
154 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.42882031 |
155 | response to laminar fluid shear stress (GO:0034616) | 2.38871832 |
156 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.37187062 |
157 | neuromuscular process controlling balance (GO:0050885) | 2.35403183 |
158 | dopamine receptor signaling pathway (GO:0007212) | 2.35281253 |
159 | regulation of early endosome to late endosome transport (GO:2000641) | 2.35042918 |
160 | cellular response to monoamine stimulus (GO:0071868) | 2.33985491 |
161 | cellular response to catecholamine stimulus (GO:0071870) | 2.33985491 |
162 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.33155541 |
163 | regulation of defense response to virus by virus (GO:0050690) | 2.31952617 |
164 | barbed-end actin filament capping (GO:0051016) | 2.30507157 |
165 | potassium ion homeostasis (GO:0055075) | 2.30200373 |
166 | protein localization to endosome (GO:0036010) | 2.29828115 |
167 | response to parathyroid hormone (GO:0071107) | 2.29065613 |
168 | neuronal ion channel clustering (GO:0045161) | 2.27200782 |
169 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.25543026 |
170 | regulation of synaptic plasticity (GO:0048167) | 2.24688404 |
171 | negative regulation of type 2 immune response (GO:0002829) | 2.23748130 |
172 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.22936070 |
173 | amino acid import (GO:0043090) | 2.22893693 |
174 | activation of JUN kinase activity (GO:0007257) | 2.21524351 |
175 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.20316495 |
176 | B cell receptor signaling pathway (GO:0050853) | 2.20011713 |
177 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.19985847 |
178 | positive regulation of fibroblast migration (GO:0010763) | 2.19639487 |
179 | cellular response to epinephrine stimulus (GO:0071872) | 2.18309917 |
180 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.18274915 |
181 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.16919878 |
182 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.16089117 |
183 | regulation of protein dephosphorylation (GO:0035304) | 2.15875870 |
184 | detection of bacterium (GO:0016045) | 2.13218130 |
185 | regulation of synapse structural plasticity (GO:0051823) | 2.12514710 |
186 | adherens junction assembly (GO:0034333) | 2.10753309 |
187 | layer formation in cerebral cortex (GO:0021819) | 2.09804783 |
188 | potassium ion import (GO:0010107) | 2.09753280 |
189 | negative regulation of myotube differentiation (GO:0010832) | 2.09327870 |
190 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.09192558 |
191 | cell-substrate adherens junction assembly (GO:0007045) | 2.09054240 |
192 | focal adhesion assembly (GO:0048041) | 2.09054240 |
193 | adenosine receptor signaling pathway (GO:0001973) | 2.08926203 |
194 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.08071868 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.78564937 |
2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.53584919 |
3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.16729904 |
4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.79638030 |
5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.35721771 |
6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.69615528 |
7 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.57808739 |
8 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.30143877 |
9 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.24804949 |
10 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.19436253 |
11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.18717516 |
12 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.10943273 |
13 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.03894236 |
14 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.98323201 |
15 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.88665070 |
16 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.72733778 |
17 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.71836361 |
18 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.71540663 |
19 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.71061502 |
20 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.69886693 |
21 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.68975331 |
22 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.64206772 |
23 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.63891764 |
24 | KDM2B_26808549_Chip-Seq_K562_Human | 1.60303518 |
25 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.58919713 |
26 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.57641525 |
27 | * MAF_26560356_Chip-Seq_TH1_Human | 1.56365377 |
28 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.55176722 |
29 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.55176722 |
30 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.54972160 |
31 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.53799252 |
32 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.50911574 |
33 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.49027236 |
34 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.48081917 |
35 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.43751911 |
36 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.43447620 |
37 | UTX_26944678_Chip-Seq_JUKART_Human | 1.40518037 |
38 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.37841772 |
39 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.37538251 |
40 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.37117888 |
41 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.35441739 |
42 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.35379077 |
43 | * MAF_26560356_Chip-Seq_TH2_Human | 1.35290827 |
44 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34932379 |
45 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.32896046 |
46 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.32885507 |
47 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.32686284 |
48 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.30618131 |
49 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.28685075 |
50 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.27995641 |
51 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.26954809 |
52 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.26463458 |
53 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.26012918 |
54 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.25156045 |
55 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.24353688 |
56 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.23704992 |
57 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.22950621 |
58 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.22444042 |
59 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.22241466 |
60 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.22238966 |
61 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.21772982 |
62 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.20903190 |
63 | * P68_20966046_ChIP-Seq_HELA_Human | 1.20193749 |
64 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.19311591 |
65 | GATA1_19941826_ChIP-Seq_K562_Human | 1.18442503 |
66 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.17065222 |
67 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.16797788 |
68 | SPI1_23127762_ChIP-Seq_K562_Human | 1.15323360 |
69 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.15256623 |
70 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.14088787 |
71 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.13867446 |
72 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.13220767 |
73 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.13192247 |
74 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.13151737 |
75 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12187284 |
76 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.11980711 |
77 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.11729890 |
78 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11324096 |
79 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.09865061 |
80 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.09557581 |
81 | SA1_27219007_Chip-Seq_Bcells_Human | 1.08094396 |
82 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.07939520 |
83 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.06955079 |
84 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.06801124 |
85 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.06662867 |
86 | ATF3_27146783_Chip-Seq_COLON_Human | 1.06275232 |
87 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.05576072 |
88 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.05563952 |
89 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.04031652 |
90 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.03497313 |
91 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03482936 |
92 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.02701784 |
93 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.01788886 |
94 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.01352904 |
95 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.01202107 |
96 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.01187299 |
97 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.01122187 |
98 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.01096728 |
99 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.00517248 |
100 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.00250545 |
101 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.00128256 |
102 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.99037548 |
103 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.98626743 |
104 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.97740464 |
105 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.97143633 |
106 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.96917360 |
107 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.96370081 |
108 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.96042393 |
109 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.95997248 |
110 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.95997248 |
111 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.95858625 |
112 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.94652014 |
113 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.93429372 |
114 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93409085 |
115 | MYC_22102868_ChIP-Seq_BL_Human | 0.93047216 |
116 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.92962521 |
117 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.92731413 |
118 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.91898894 |
119 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.90932737 |
120 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90709756 |
121 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.90525364 |
122 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.89647856 |
123 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.88862455 |
124 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.88689500 |
125 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.87896391 |
126 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86884177 |
127 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.86291568 |
128 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.86128290 |
129 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.85271276 |
130 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.85042274 |
131 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.84936523 |
132 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.84925957 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 4.64398767 |
2 | MP0005360_urolithiasis | 4.49750419 |
3 | MP0002837_dystrophic_cardiac_calcinosis | 3.85267554 |
4 | MP0005085_abnormal_gallbladder_physiolo | 3.57888700 |
5 | MP0005365_abnormal_bile_salt | 3.43577530 |
6 | MP0000751_myopathy | 2.90649441 |
7 | MP0003705_abnormal_hypodermis_morpholog | 2.64776198 |
8 | MP0008875_abnormal_xenobiotic_pharmacok | 2.61954099 |
9 | MP0005083_abnormal_biliary_tract | 2.60951549 |
10 | MP0003252_abnormal_bile_duct | 2.60707269 |
11 | MP0009840_abnormal_foam_cell | 2.45516635 |
12 | MP0004084_abnormal_cardiac_muscle | 2.38169243 |
13 | MP0004270_analgesia | 2.38033359 |
14 | MP0003436_decreased_susceptibility_to | 2.36533073 |
15 | MP0004130_abnormal_muscle_cell | 2.34954733 |
16 | MP0010329_abnormal_lipoprotein_level | 2.24520688 |
17 | MP0003635_abnormal_synaptic_transmissio | 2.23842982 |
18 | MP0008569_lethality_at_weaning | 2.22885684 |
19 | MP0003646_muscle_fatigue | 2.21762725 |
20 | MP0003879_abnormal_hair_cell | 2.11685062 |
21 | MP0003195_calcinosis | 2.11532176 |
22 | MP0004036_abnormal_muscle_relaxation | 2.08805859 |
23 | MP0003763_abnormal_thymus_physiology | 2.08264226 |
24 | MP0005423_abnormal_somatic_nervous | 2.04267215 |
25 | MP0005332_abnormal_amino_acid | 1.97237111 |
26 | MP0005330_cardiomyopathy | 1.94178100 |
27 | MP0002064_seizures | 1.92091796 |
28 | MP0001666_abnormal_nutrient_absorption | 1.89798121 |
29 | MP0002909_abnormal_adrenal_gland | 1.88765995 |
30 | MP0001348_abnormal_lacrimal_gland | 1.86117318 |
31 | MP0003690_abnormal_glial_cell | 1.86019611 |
32 | MP0004087_abnormal_muscle_fiber | 1.79331694 |
33 | MP0008961_abnormal_basal_metabolism | 1.79005285 |
34 | MP0003806_abnormal_nucleotide_metabolis | 1.78508925 |
35 | MP0000749_muscle_degeneration | 1.77185237 |
36 | MP0002063_abnormal_learning/memory/cond | 1.74719111 |
37 | MP0003172_abnormal_lysosome_physiology | 1.74277844 |
38 | MP0004215_abnormal_myocardial_fiber | 1.66987953 |
39 | MP0003880_abnormal_central_pattern | 1.64555069 |
40 | MP0003191_abnormal_cellular_cholesterol | 1.63863474 |
41 | MP0002118_abnormal_lipid_homeostasis | 1.63668962 |
42 | MP0000747_muscle_weakness | 1.63631644 |
43 | MP0005451_abnormal_body_composition | 1.61224585 |
44 | MP0002269_muscular_atrophy | 1.60574579 |
45 | MP0004043_abnormal_pH_regulation | 1.58579174 |
46 | MP0003300_gastrointestinal_ulcer | 1.51885110 |
47 | MP0003279_aneurysm | 1.47918137 |
48 | MP0005409_darkened_coat_color | 1.47048583 |
49 | MP0003329_amyloid_beta_deposits | 1.46105400 |
50 | MP0008260_abnormal_autophagy | 1.45197648 |
51 | MP0002822_catalepsy | 1.43281528 |
52 | MP0005387_immune_system_phenotype | 1.42004728 |
53 | MP0001790_abnormal_immune_system | 1.42004728 |
54 | MP0005000_abnormal_immune_tolerance | 1.41856054 |
55 | MP0003283_abnormal_digestive_organ | 1.40008655 |
56 | MP0004947_skin_inflammation | 1.39817395 |
57 | MP0001501_abnormal_sleep_pattern | 1.38993240 |
58 | MP0005666_abnormal_adipose_tissue | 1.38458784 |
59 | MP0009780_abnormal_chondrocyte_physiolo | 1.38395275 |
60 | MP0004145_abnormal_muscle_electrophysio | 1.37364583 |
61 | MP0005319_abnormal_enzyme/_coenzyme | 1.36727585 |
62 | MP0004859_abnormal_synaptic_plasticity | 1.36617527 |
63 | MP0000920_abnormal_myelination | 1.36084980 |
64 | MP0000609_abnormal_liver_physiology | 1.35789159 |
65 | MP0009745_abnormal_behavioral_response | 1.35430576 |
66 | MP0003724_increased_susceptibility_to | 1.33552320 |
67 | MP0009643_abnormal_urine_homeostasis | 1.31996366 |
68 | MP0005025_abnormal_response_to | 1.30896800 |
69 | MP0002734_abnormal_mechanical_nocicepti | 1.30334352 |
70 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.30330729 |
71 | MP0002138_abnormal_hepatobiliary_system | 1.29216041 |
72 | MP0002972_abnormal_cardiac_muscle | 1.28632597 |
73 | MP0005620_abnormal_muscle_contractility | 1.27011292 |
74 | MP0004185_abnormal_adipocyte_glucose | 1.25870711 |
75 | MP0000685_abnormal_immune_system | 1.25417627 |
76 | MP0003866_abnormal_defecation | 1.24956825 |
77 | MP0001800_abnormal_humoral_immune | 1.24273277 |
78 | MP0005166_decreased_susceptibility_to | 1.23354626 |
79 | MP0010630_abnormal_cardiac_muscle | 1.23106636 |
80 | MP0005671_abnormal_response_to | 1.23076651 |
81 | MP0000750_abnormal_muscle_regeneration | 1.22543645 |
82 | MP0009278_abnormal_bone_marrow | 1.21014322 |
83 | MP0003137_abnormal_impulse_conducting | 1.19310252 |
84 | MP0000759_abnormal_skeletal_muscle | 1.17947161 |
85 | MP0010234_abnormal_vibrissa_follicle | 1.17665609 |
86 | MP0006036_abnormal_mitochondrial_physio | 1.17492686 |
87 | MP0008775_abnormal_heart_ventricle | 1.17117400 |
88 | MP0001544_abnormal_cardiovascular_syste | 1.16153066 |
89 | MP0005385_cardiovascular_system_phenoty | 1.16153066 |
90 | MP0005375_adipose_tissue_phenotype | 1.15410748 |
91 | MP0002106_abnormal_muscle_physiology | 1.15211074 |
92 | MP0010155_abnormal_intestine_physiology | 1.13896508 |
93 | MP0001849_ear_inflammation | 1.13292641 |
94 | MP0002572_abnormal_emotion/affect_behav | 1.12760149 |
95 | MP0002420_abnormal_adaptive_immunity | 1.12216365 |
96 | MP0002078_abnormal_glucose_homeostasis | 1.11983983 |
97 | MP0006082_CNS_inflammation | 1.11056069 |
98 | MP0000013_abnormal_adipose_tissue | 1.10877520 |
99 | MP0004858_abnormal_nervous_system | 1.10438904 |
100 | MP0004233_abnormal_muscle_weight | 1.10384647 |
101 | MP0001819_abnormal_immune_cell | 1.09757709 |
102 | MP0000678_abnormal_parathyroid_gland | 1.09660578 |
103 | MP0001851_eye_inflammation | 1.09498929 |
104 | MP0001533_abnormal_skeleton_physiology | 1.09429777 |
105 | MP0003091_abnormal_cell_migration | 1.08736003 |
106 | MP0002419_abnormal_innate_immunity | 1.08541680 |
107 | MP0002933_joint_inflammation | 1.08328771 |
108 | MP0002272_abnormal_nervous_system | 1.08118135 |
109 | MP0006138_congestive_heart_failure | 1.07892518 |
110 | MP0009333_abnormal_splenocyte_physiolog | 1.07579659 |
111 | MP0002723_abnormal_immune_serum | 1.05069330 |
112 | MP0005670_abnormal_white_adipose | 1.05002588 |
113 | MP0002249_abnormal_larynx_morphology | 1.03814801 |
114 | MP0004019_abnormal_vitamin_homeostasis | 1.02596142 |
115 | MP0000604_amyloidosis | 1.02374469 |
116 | MP0001765_abnormal_ion_homeostasis | 1.00663144 |
117 | MP0001835_abnormal_antigen_presentation | 1.00590209 |
118 | MP0001502_abnormal_circadian_rhythm | 0.99992507 |
119 | MP0005167_abnormal_blood-brain_barrier | 0.99929186 |
120 | MP0004085_abnormal_heartbeat | 0.99487618 |
121 | MP0004510_myositis | 0.99276013 |
122 | MP0001873_stomach_inflammation | 0.97918285 |
123 | MP0000003_abnormal_adipose_tissue | 0.97192422 |
124 | MP0002998_abnormal_bone_remodeling | 0.96820620 |
125 | MP0000681_abnormal_thyroid_gland | 0.95109037 |
126 | MP0010368_abnormal_lymphatic_system | 0.94427832 |
127 | MP0001970_abnormal_pain_threshold | 0.93953035 |
128 | MP0001756_abnormal_urination | 0.93827748 |
129 | MP0003868_abnormal_feces_composition | 0.92954453 |
130 | MP0003634_abnormal_glial_cell | 0.92858326 |
131 | MP0001486_abnormal_startle_reflex | 0.92814729 |
132 | MP0005369_muscle_phenotype | 0.92477315 |
133 | MP0002733_abnormal_thermal_nociception | 0.92392110 |
134 | MP0005535_abnormal_body_temperature | 0.92008466 |
135 | MP0003183_abnormal_peptide_metabolism | 0.89673041 |
136 | MP0002452_abnormal_antigen_presenting | 0.89629853 |
137 | MP0000858_altered_metastatic_potential | 0.87895862 |
138 | MP0002971_abnormal_brown_adipose | 0.87215937 |
139 | MP0003123_paternal_imprinting | 0.87143799 |
140 | MP0003828_pulmonary_edema | 0.87086672 |
141 | MP0002398_abnormal_bone_marrow | 0.85874700 |
142 | MP0002234_abnormal_pharynx_morphology | 0.85337031 |
143 | MP0003075_altered_response_to | 0.85200476 |
144 | MP0000703_abnormal_thymus_morphology | 0.85010721 |
145 | MP0004484_altered_response_of | 0.84910860 |
146 | MP0001440_abnormal_grooming_behavior | 0.84904259 |
147 | MP0002877_abnormal_melanocyte_morpholog | 0.83522064 |
148 | MP0000716_abnormal_immune_system | 0.81754514 |
149 | MP0004381_abnormal_hair_follicle | 0.80883035 |
150 | MP0005058_abnormal_lysosome_morphology | 0.80879569 |
151 | MP0000230_abnormal_systemic_arterial | 0.80801692 |
152 | MP0005464_abnormal_platelet_physiology | 0.80590715 |
153 | MP0002089_abnormal_postnatal_growth/wei | 0.77730467 |
154 | MP0003656_abnormal_erythrocyte_physiolo | 0.77481660 |
155 | MP0003633_abnormal_nervous_system | 0.76683568 |
156 | MP0003221_abnormal_cardiomyocyte_apopto | 0.76148618 |
157 | MP0003045_fibrosis | 0.75403886 |
158 | MP0005636_abnormal_mineral_homeostasis | 0.74984499 |
159 | MP0008874_decreased_physiological_sensi | 0.71640856 |
160 | MP0005334_abnormal_fat_pad | 0.70633808 |
161 | MP0003303_peritoneal_inflammation | 0.70453555 |
162 | MP0003566_abnormal_cell_adhesion | 0.69202753 |
163 | MP0005623_abnormal_meninges_morphology | 0.67570216 |
164 | MP0008438_abnormal_cutaneous_collagen | 0.66738948 |
165 | MP0009642_abnormal_blood_homeostasis | 0.65102049 |
166 | MP0005448_abnormal_energy_balance | 0.64803155 |
167 | MP0000598_abnormal_liver_morphology | 0.64150260 |
168 | MP0005165_increased_susceptibility_to | 0.63226185 |
169 | MP0002896_abnormal_bone_mineralization | 0.60652354 |
170 | MP0003953_abnormal_hormone_level | 0.59921915 |
171 | MP0001958_emphysema | 0.57618049 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Obstructive sleep apnea (HP:0002870) | 4.62094454 |
2 | Deep venous thrombosis (HP:0002625) | 4.00338635 |
3 | Sudden death (HP:0001699) | 3.90179127 |
4 | Exercise-induced myalgia (HP:0003738) | 3.71751586 |
5 | Ketoacidosis (HP:0001993) | 3.69737165 |
6 | Ketosis (HP:0001946) | 3.66546892 |
7 | Supranuclear gaze palsy (HP:0000605) | 3.57867254 |
8 | Myoglobinuria (HP:0002913) | 3.55600429 |
9 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.53135676 |
10 | Xanthomatosis (HP:0000991) | 3.48975975 |
11 | Hypoglycemic coma (HP:0001325) | 3.26538074 |
12 | Exercise-induced muscle cramps (HP:0003710) | 3.24274987 |
13 | Diplopia (HP:0000651) | 3.23226019 |
14 | Abnormality of binocular vision (HP:0011514) | 3.23226019 |
15 | Eczematoid dermatitis (HP:0000976) | 3.22197753 |
16 | Myokymia (HP:0002411) | 3.20716187 |
17 | Ankle clonus (HP:0011448) | 3.19729921 |
18 | Gout (HP:0001997) | 3.10502057 |
19 | Papilledema (HP:0001085) | 3.08146511 |
20 | Hyporeflexia of lower limbs (HP:0002600) | 3.02835046 |
21 | Hyperammonemia (HP:0001987) | 3.01558678 |
22 | Intrahepatic cholestasis (HP:0001406) | 2.98783308 |
23 | Bundle branch block (HP:0011710) | 2.96077256 |
24 | Asymmetric septal hypertrophy (HP:0001670) | 2.93601567 |
25 | Annular pancreas (HP:0001734) | 2.93546288 |
26 | Ventricular tachycardia (HP:0004756) | 2.91943902 |
27 | Neurofibrillary tangles (HP:0002185) | 2.88651606 |
28 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.85542660 |
29 | Right ventricular cardiomyopathy (HP:0011663) | 2.82467544 |
30 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.78371128 |
31 | Hyperglycinuria (HP:0003108) | 2.77241454 |
32 | Ventricular fibrillation (HP:0001663) | 2.72272143 |
33 | Distal lower limb muscle weakness (HP:0009053) | 2.69024551 |
34 | Muscle fiber splitting (HP:0003555) | 2.67453719 |
35 | Hyperlipoproteinemia (HP:0010980) | 2.67011738 |
36 | Calf muscle hypertrophy (HP:0008981) | 2.61993962 |
37 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.60776847 |
38 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.57472909 |
39 | Abnormality of glycine metabolism (HP:0010895) | 2.57472909 |
40 | Abnormality of the nasal mucosa (HP:0000433) | 2.56809097 |
41 | Abnormality of the Achilles tendon (HP:0005109) | 2.54914753 |
42 | Difficulty running (HP:0009046) | 2.54616069 |
43 | Late onset (HP:0003584) | 2.53421628 |
44 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.50896039 |
45 | Nasal polyposis (HP:0100582) | 2.50866087 |
46 | Atrioventricular block (HP:0001678) | 2.50032917 |
47 | Cerebral inclusion bodies (HP:0100314) | 2.49662165 |
48 | Increased connective tissue (HP:0009025) | 2.45985461 |
49 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.44136432 |
50 | Heart block (HP:0012722) | 2.42338635 |
51 | Cellulitis (HP:0100658) | 2.40490619 |
52 | Hypoalphalipoproteinemia (HP:0003233) | 2.39896046 |
53 | Increased IgE level (HP:0003212) | 2.39490709 |
54 | Lymphangioma (HP:0100764) | 2.38811393 |
55 | Complement deficiency (HP:0004431) | 2.36306197 |
56 | Neuronal loss in central nervous system (HP:0002529) | 2.33659844 |
57 | Abnormal atrioventricular conduction (HP:0005150) | 2.31880993 |
58 | Myopathic facies (HP:0002058) | 2.31451865 |
59 | Hyperglycinemia (HP:0002154) | 2.31427163 |
60 | Syncope (HP:0001279) | 2.31340347 |
61 | Distal lower limb amyotrophy (HP:0008944) | 2.30877023 |
62 | Neonatal onset (HP:0003623) | 2.30807189 |
63 | Cholelithiasis (HP:0001081) | 2.27969106 |
64 | Achilles tendon contracture (HP:0001771) | 2.27634623 |
65 | Visual hallucinations (HP:0002367) | 2.27483169 |
66 | Palpitations (HP:0001962) | 2.26905877 |
67 | Ventricular arrhythmia (HP:0004308) | 2.26868374 |
68 | EMG: myopathic abnormalities (HP:0003458) | 2.25649546 |
69 | Hypobetalipoproteinemia (HP:0003563) | 2.25073224 |
70 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.24829149 |
71 | Skin nodule (HP:0200036) | 2.24720812 |
72 | Abnormality of the calf musculature (HP:0001430) | 2.22141382 |
73 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.20023744 |
74 | Rhabdomyolysis (HP:0003201) | 2.20020589 |
75 | Hypolipoproteinemia (HP:0010981) | 2.16658073 |
76 | Lower limb amyotrophy (HP:0007210) | 2.14942154 |
77 | Myotonia (HP:0002486) | 2.14537646 |
78 | Growth hormone excess (HP:0000845) | 2.13725372 |
79 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.12882504 |
80 | Subaortic stenosis (HP:0001682) | 2.12882504 |
81 | Abnormal gallbladder morphology (HP:0012437) | 2.12850970 |
82 | Increased variability in muscle fiber diameter (HP:0003557) | 2.12127254 |
83 | Spinal canal stenosis (HP:0003416) | 2.11995033 |
84 | Gastrointestinal stroma tumor (HP:0100723) | 2.11508965 |
85 | Abnormality of purine metabolism (HP:0004352) | 2.11459011 |
86 | Prolonged QT interval (HP:0001657) | 2.11325427 |
87 | Atrial fibrillation (HP:0005110) | 2.10675280 |
88 | Foot dorsiflexor weakness (HP:0009027) | 2.09290672 |
89 | Hemiplegia (HP:0002301) | 2.08369933 |
90 | Difficulty climbing stairs (HP:0003551) | 2.07437197 |
91 | Type 1 muscle fiber predominance (HP:0003803) | 2.07384602 |
92 | Muscle stiffness (HP:0003552) | 2.06773798 |
93 | Stridor (HP:0010307) | 2.06056664 |
94 | Slow saccadic eye movements (HP:0000514) | 2.03266193 |
95 | Lipoatrophy (HP:0100578) | 2.01923446 |
96 | Primary atrial arrhythmia (HP:0001692) | 2.01349442 |
97 | Abnormality of the common coagulation pathway (HP:0010990) | 2.00103949 |
98 | Rapidly progressive (HP:0003678) | 1.98659907 |
99 | Action tremor (HP:0002345) | 1.97797901 |
100 | Conjunctival hamartoma (HP:0100780) | 1.96998952 |
101 | Epidermoid cyst (HP:0200040) | 1.96077915 |
102 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.95972008 |
103 | Dicarboxylic aciduria (HP:0003215) | 1.95972008 |
104 | Truncal ataxia (HP:0002078) | 1.95877806 |
105 | Dysmetric saccades (HP:0000641) | 1.94797789 |
106 | Broad metatarsal (HP:0001783) | 1.94756538 |
107 | Emphysema (HP:0002097) | 1.94313254 |
108 | Spontaneous hematomas (HP:0007420) | 1.94168736 |
109 | Torticollis (HP:0000473) | 1.93655388 |
110 | Hyperacusis (HP:0010780) | 1.93497269 |
111 | Tetraplegia (HP:0002445) | 1.93088516 |
112 | Round ear (HP:0100830) | 1.92980350 |
113 | Polygenic inheritance (HP:0010982) | 1.91776735 |
114 | Polycythemia (HP:0001901) | 1.91588903 |
115 | Abnormality of the foot musculature (HP:0001436) | 1.91458009 |
116 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.91047405 |
117 | Upper limb amyotrophy (HP:0009129) | 1.90767913 |
118 | Distal upper limb amyotrophy (HP:0007149) | 1.90767913 |
119 | Colitis (HP:0002583) | 1.90390968 |
120 | Broad face (HP:0000283) | 1.89841621 |
121 | Hamartoma of the eye (HP:0010568) | 1.89703828 |
122 | Depression (HP:0000716) | 1.89616499 |
123 | Supraventricular tachycardia (HP:0004755) | 1.89480934 |
124 | Supraventricular arrhythmia (HP:0005115) | 1.88839940 |
125 | Increased purine levels (HP:0004368) | 1.88164650 |
126 | Hyperuricemia (HP:0002149) | 1.88164650 |
127 | Focal motor seizures (HP:0011153) | 1.88138267 |
128 | Delayed CNS myelination (HP:0002188) | 1.87334163 |
129 | Lower limb asymmetry (HP:0100559) | 1.86746723 |
130 | Metabolic acidosis (HP:0001942) | 1.86457714 |
131 | Abnormality of the fingertips (HP:0001211) | 1.85483389 |
132 | Protrusio acetabuli (HP:0003179) | 1.85410100 |
133 | Peripheral hypomyelination (HP:0007182) | 1.84717726 |
134 | Dilated cardiomyopathy (HP:0001644) | 1.84260751 |
135 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.84030206 |
136 | Abnormality of macrophages (HP:0004311) | 1.83703779 |
137 | Hyperparathyroidism (HP:0000843) | 1.83608382 |
138 | Long toe (HP:0010511) | 1.82911464 |
139 | Abnormality of the lower motor neuron (HP:0002366) | 1.82548690 |
140 | Myositis (HP:0100614) | 1.82167103 |
141 | Cholecystitis (HP:0001082) | 1.81933415 |
142 | Abnormal gallbladder physiology (HP:0012438) | 1.81933415 |
143 | Limb-girdle muscle atrophy (HP:0003797) | 1.81845107 |
144 | EMG: neuropathic changes (HP:0003445) | 1.81356505 |
145 | Sleep apnea (HP:0010535) | 1.81244014 |
146 | Cerebral aneurysm (HP:0004944) | 1.80576395 |
147 | Rigidity (HP:0002063) | 1.80294199 |
148 | Hypercortisolism (HP:0001578) | 1.79327873 |
149 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.78542227 |
150 | Interstitial pulmonary disease (HP:0006530) | 1.78522674 |
151 | Easy fatigability (HP:0003388) | 1.78235707 |
152 | Abnormal eating behavior (HP:0100738) | 1.78216081 |
153 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.77696646 |
154 | Hypoglycemic seizures (HP:0002173) | 1.77622615 |
155 | Epileptic encephalopathy (HP:0200134) | 1.77269365 |
156 | Recurrent abscess formation (HP:0002722) | 1.76457888 |
157 | Hyperglycemia (HP:0003074) | 1.75957631 |
158 | Gastrointestinal inflammation (HP:0004386) | 1.75869144 |
159 | Back pain (HP:0003418) | 1.75440942 |
160 | Axonal loss (HP:0003447) | 1.75099087 |
161 | Turricephaly (HP:0000262) | 1.71839421 |
162 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.71426275 |
163 | Meningitis (HP:0001287) | 1.70977910 |
164 | Postural instability (HP:0002172) | 1.70855316 |
165 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.69103240 |
166 | Dysostosis multiplex (HP:0000943) | 1.67868546 |
167 | Spastic gait (HP:0002064) | 1.67717065 |
168 | Agammaglobulinemia (HP:0004432) | 1.67042107 |
169 | Focal seizures (HP:0007359) | 1.67034841 |
170 | Shallow orbits (HP:0000586) | 1.65273617 |
171 | Chronic obstructive pulmonary disease (HP:0006510) | 1.65214155 |
172 | Obstructive lung disease (HP:0006536) | 1.65214155 |
173 | Onion bulb formation (HP:0003383) | 1.65143639 |
174 | Recurrent bacterial skin infections (HP:0005406) | 1.64217659 |
175 | Gastrointestinal infarctions (HP:0005244) | 1.64097208 |
176 | Aneurysm (HP:0002617) | 1.63874648 |
177 | Pointed chin (HP:0000307) | 1.62933890 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TRIB3 | 5.18754574 |
2 | PRPF4B | 4.01164145 |
3 | PKN2 | 3.92134922 |
4 | TTN | 2.91987627 |
5 | BCKDK | 2.82699506 |
6 | ERN1 | 2.59435105 |
7 | RIPK4 | 2.59339513 |
8 | MAP4K1 | 2.33617697 |
9 | LMTK2 | 2.18326746 |
10 | PHKG1 | 2.06495915 |
11 | PHKG2 | 2.06495915 |
12 | RIPK1 | 2.05573320 |
13 | SIK1 | 2.00431075 |
14 | MAP3K13 | 1.85648034 |
15 | PTK6 | 1.76554340 |
16 | KSR2 | 1.71628495 |
17 | SMG1 | 1.65590357 |
18 | FGFR4 | 1.64523443 |
19 | PDGFRA | 1.55569450 |
20 | PRKD3 | 1.55451941 |
21 | MAP3K7 | 1.53780072 |
22 | DMPK | 1.49261567 |
23 | TNK2 | 1.43801431 |
24 | NEK1 | 1.42072290 |
25 | WNK4 | 1.39545458 |
26 | TAOK1 | 1.37652256 |
27 | CAMKK1 | 1.34256760 |
28 | DAPK2 | 1.32271294 |
29 | FES | 1.31324848 |
30 | EEF2K | 1.28611821 |
31 | MAP3K10 | 1.28054936 |
32 | PAK6 | 1.26651869 |
33 | ZAP70 | 1.24603430 |
34 | EPHB1 | 1.23514655 |
35 | ICK | 1.23435299 |
36 | STK38 | 1.22470662 |
37 | RET | 1.19738060 |
38 | MAP3K9 | 1.15855298 |
39 | PRKCH | 1.14804655 |
40 | TYK2 | 1.13881556 |
41 | ARAF | 1.12225860 |
42 | TESK1 | 1.11173977 |
43 | PINK1 | 1.09148537 |
44 | PDK3 | 1.08781174 |
45 | PDK4 | 1.08781174 |
46 | PAK3 | 1.07694624 |
47 | NTRK1 | 1.07105090 |
48 | MAP2K4 | 1.05009218 |
49 | LRRK2 | 1.04671317 |
50 | MAP3K2 | 1.00034397 |
51 | MAP3K1 | 0.99951524 |
52 | OBSCN | 0.98557788 |
53 | MYLK | 0.97570382 |
54 | PRKD1 | 0.97256749 |
55 | TAOK2 | 0.95499425 |
56 | NTRK2 | 0.93505841 |
57 | PTK2 | 0.92060881 |
58 | TYRO3 | 0.89645592 |
59 | BMX | 0.89485590 |
60 | PDPK1 | 0.88342603 |
61 | CSK | 0.87010916 |
62 | TBK1 | 0.86306313 |
63 | ILK | 0.85562451 |
64 | DAPK3 | 0.83620210 |
65 | MARK1 | 0.79244970 |
66 | SIK3 | 0.76338471 |
67 | INSRR | 0.73470420 |
68 | BTK | 0.72357829 |
69 | MAPK7 | 0.71769300 |
70 | JAK2 | 0.71161411 |
71 | PDK1 | 0.70926241 |
72 | FGFR3 | 0.69982747 |
73 | DYRK1B | 0.69860482 |
74 | MAP3K3 | 0.69716719 |
75 | ALK | 0.69393325 |
76 | CDK12 | 0.69188078 |
77 | LATS2 | 0.68614916 |
78 | WNK1 | 0.67853419 |
79 | CDC42BPA | 0.67717140 |
80 | TAOK3 | 0.67589982 |
81 | MAP2K3 | 0.67076272 |
82 | CAMK1 | 0.66500978 |
83 | FLT3 | 0.66361537 |
84 | MAPK12 | 0.65739777 |
85 | PRKD2 | 0.64840584 |
86 | ITK | 0.64723531 |
87 | GRK5 | 0.64384736 |
88 | DDR2 | 0.63941118 |
89 | SYK | 0.63524577 |
90 | SGK223 | 0.63354054 |
91 | SGK494 | 0.63354054 |
92 | HCK | 0.62970610 |
93 | MAPK11 | 0.62389318 |
94 | PRKAA1 | 0.61762683 |
95 | FER | 0.61370577 |
96 | MAP2K2 | 0.61115953 |
97 | CAMK1G | 0.60625457 |
98 | SGK3 | 0.60541054 |
99 | MAP3K11 | 0.59525542 |
100 | BLK | 0.58082445 |
101 | ROCK1 | 0.57976419 |
102 | JAK1 | 0.57269894 |
103 | MAP2K1 | 0.56270997 |
104 | MAPK4 | 0.56063493 |
105 | FYN | 0.55802466 |
106 | MAPK15 | 0.55308228 |
107 | STK11 | 0.54916962 |
108 | UHMK1 | 0.53473484 |
109 | NTRK3 | 0.52998649 |
110 | MST1R | 0.52711960 |
111 | JAK3 | 0.52073477 |
112 | CAMK4 | 0.51608912 |
113 | PIK3CA | 0.51541625 |
114 | EPHA4 | 0.51451566 |
115 | IRAK4 | 0.50927954 |
116 | RPS6KC1 | 0.50501383 |
117 | RPS6KL1 | 0.50501383 |
118 | MTOR | 0.50024870 |
119 | EPHB2 | 0.48856595 |
120 | PTK2B | 0.48386455 |
121 | PRKAA2 | 0.48052274 |
122 | MINK1 | 0.47420572 |
123 | CAMK1D | 0.47349969 |
124 | CDK19 | 0.47202877 |
125 | MARK2 | 0.46791984 |
126 | GRK6 | 0.46418502 |
127 | IRAK2 | 0.46368697 |
128 | MAP2K6 | 0.46160558 |
129 | PDGFRB | 0.45767466 |
130 | TIE1 | 0.45484242 |
131 | SCYL2 | 0.44833541 |
132 | PRKG2 | 0.44669235 |
133 | CAMK2B | 0.44324682 |
134 | CAMKK2 | 0.43594855 |
135 | SIK2 | 0.43341780 |
136 | LCK | 0.42925685 |
137 | MAPKAPK3 | 0.42588007 |
138 | PRKACG | 0.42519825 |
139 | MAP3K4 | 0.40847124 |
140 | HIPK2 | 0.39963822 |
141 | RPS6KA2 | 0.39858739 |
142 | CDK5 | 0.39644156 |
143 | PRKCZ | 0.38483521 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.61135898 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.43212821 |
3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.76298174 |
4 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.64038752 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.58496140 |
6 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.53249722 |
7 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.51053138 |
8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.32010588 |
9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.27340287 |
10 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.16487600 |
11 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.14254251 |
12 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.10411440 |
13 | Long-term potentiation_Homo sapiens_hsa04720 | 2.03678278 |
14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.03224613 |
15 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.98323621 |
16 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.75625278 |
17 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.74958144 |
18 | Bile secretion_Homo sapiens_hsa04976 | 1.72412436 |
19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.71260886 |
20 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.60813410 |
21 | Carbon metabolism_Homo sapiens_hsa01200 | 1.58389887 |
22 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.48976990 |
23 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.43827168 |
24 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.40023286 |
25 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.36196724 |
26 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.34821102 |
27 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.32211363 |
28 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.29944482 |
29 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.29457246 |
30 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.25999113 |
31 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.25263631 |
32 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.21265453 |
33 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.20780115 |
34 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.20535181 |
35 | Circadian entrainment_Homo sapiens_hsa04713 | 1.19844794 |
36 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.18962914 |
37 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.18757779 |
38 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.18068776 |
39 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.17030823 |
40 | Peroxisome_Homo sapiens_hsa04146 | 1.15726782 |
41 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.15661298 |
42 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.14968209 |
43 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.13952563 |
44 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.12763871 |
45 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.11825297 |
46 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.11504190 |
47 | Other glycan degradation_Homo sapiens_hsa00511 | 1.11281477 |
48 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.08381184 |
49 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.07866886 |
50 | Morphine addiction_Homo sapiens_hsa05032 | 1.07480669 |
51 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.05383872 |
52 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.04226470 |
53 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.01400233 |
54 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.99838835 |
55 | Cocaine addiction_Homo sapiens_hsa05030 | 0.99330481 |
56 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.99104106 |
57 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.98974555 |
58 | Leishmaniasis_Homo sapiens_hsa05140 | 0.98248196 |
59 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.97245508 |
60 | Lysine degradation_Homo sapiens_hsa00310 | 0.95940455 |
61 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.95323628 |
62 | Endocytosis_Homo sapiens_hsa04144 | 0.95163758 |
63 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.94839985 |
64 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.94819630 |
65 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.94318349 |
66 | Insulin resistance_Homo sapiens_hsa04931 | 0.94183169 |
67 | Endometrial cancer_Homo sapiens_hsa05213 | 0.92886827 |
68 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.92581704 |
69 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.92491902 |
70 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.92374826 |
71 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.92365785 |
72 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.92236704 |
73 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.91057580 |
74 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.90692535 |
75 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.90262457 |
76 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.88918767 |
77 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.86209223 |
78 | Nicotine addiction_Homo sapiens_hsa05033 | 0.85784479 |
79 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.84997718 |
80 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.84743038 |
81 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.84142685 |
82 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.83900169 |
83 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.83666436 |
84 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.83358557 |
85 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.82171901 |
86 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.81835975 |
87 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.81562285 |
88 | Melanogenesis_Homo sapiens_hsa04916 | 0.79684529 |
89 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.79652950 |
90 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.77768224 |
91 | Tuberculosis_Homo sapiens_hsa05152 | 0.77500215 |
92 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.76837942 |
93 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.76806619 |
94 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.75850004 |
95 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.75469507 |
96 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.75419354 |
97 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.74556336 |
98 | Viral myocarditis_Homo sapiens_hsa05416 | 0.74350802 |
99 | Allograft rejection_Homo sapiens_hsa05330 | 0.73956151 |
100 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.73432483 |
101 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.72898614 |
102 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.72884383 |
103 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.72737163 |
104 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.72669739 |
105 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.72630600 |
106 | Platelet activation_Homo sapiens_hsa04611 | 0.72596421 |
107 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.72086304 |
108 | Histidine metabolism_Homo sapiens_hsa00340 | 0.71642452 |
109 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.69534385 |
110 | ABC transporters_Homo sapiens_hsa02010 | 0.68807718 |
111 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.68644600 |
112 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.67729353 |
113 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.67383822 |
114 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.66709391 |
115 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.66230507 |
116 | Insulin secretion_Homo sapiens_hsa04911 | 0.65623171 |
117 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.65261507 |
118 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.64828761 |
119 | Hepatitis C_Homo sapiens_hsa05160 | 0.64700575 |
120 | Long-term depression_Homo sapiens_hsa04730 | 0.64519306 |
121 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.64368018 |
122 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.64268008 |
123 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.63912856 |
124 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.63035650 |
125 | Sulfur relay system_Homo sapiens_hsa04122 | 0.62497688 |
126 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62009653 |
127 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.61522715 |
128 | Gap junction_Homo sapiens_hsa04540 | 0.61178737 |
129 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.59962544 |
130 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.58670841 |
131 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.58419771 |
132 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.57416274 |
133 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.56683958 |
134 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.53663020 |
135 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.50310339 |
136 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.49361704 |
137 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.47640481 |
138 | Galactose metabolism_Homo sapiens_hsa00052 | 0.46588006 |
139 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.46069181 |
140 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.45948526 |
141 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.44722431 |
142 | Prion diseases_Homo sapiens_hsa05020 | 0.44141263 |
143 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.41574188 |
144 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.40832687 |
145 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.39944282 |
146 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.38294501 |
147 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.37723702 |
148 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.37723561 |
149 | Bladder cancer_Homo sapiens_hsa05219 | 0.36790378 |
150 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.35667926 |
151 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.34599854 |
152 | Retinol metabolism_Homo sapiens_hsa00830 | 0.34363784 |
153 | Renin secretion_Homo sapiens_hsa04924 | 0.33746001 |
154 | Salivary secretion_Homo sapiens_hsa04970 | 0.33732725 |
155 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.33512631 |
156 | Glioma_Homo sapiens_hsa05214 | 0.33152631 |
157 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.32591362 |
158 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.32099850 |
159 | GABAergic synapse_Homo sapiens_hsa04727 | 0.31000011 |
160 | Focal adhesion_Homo sapiens_hsa04510 | 0.30768315 |
161 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.30487552 |
162 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.30120914 |
163 | Amoebiasis_Homo sapiens_hsa05146 | 0.27472796 |
164 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.26428624 |
165 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.25597359 |